-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QHNp97Y3j23sbsovK7JcREn9oZyuLIJwJ7jrCWqCF6nwujMV+GotwDL0DrOwkzgo Z7cyFpET/ECigsl77zDdrg== 0001071739-09-000001.txt : 20090102 0001071739-09-000001.hdr.sgml : 20090101 20090102105459 ACCESSION NUMBER: 0001071739-09-000001 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20081231 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090102 DATE AS OF CHANGE: 20090102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 09500390 BUSINESS ADDRESS: STREET 1: 7711 CARONDELET AVE CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7711 CARONDELET AVE STREET 2: SUITE 800 CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 form8k.htm FORM 8-K form8k.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 
 
 

 
FORM 8-K 


 
 
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

Date of report (Date of earliest event reported): December 31, 2008
 
CENTENE CORPORATION 
(Exact name of registrant as specified in its charter)
 
         
Delaware
(State or other jurisdiction of incorporation) 
 
001-31826
(Commission file number) 
 
42-1406317
(IRS Employer Identification No.)
 
7711 Carondelet Avenue, St. Louis, Missouri 63105
(Address of principal executive office and zip code) 
Registrant’s telephone number, including area code: (314) 725-4477 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 



 
ITEM 7.01 REGULATION FD DISCLOSURE

On December 31, 2008, the Company issued a press release announcing that it has received a termination notice from AMERIGROUP Corporation relating to the previously disclosed agreement to sell certain assets of University Health Plans, Inc. in the State of New Jersey.  The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the website cited in the press release is not a part of this report.
 
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

99.1  Press release of Centene Corporation issued December 31, 2008.
   
 

SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
         
Date: January 2, 2009
CENTENE CORPORATION
 
 
 
By:  
/s/ KEITH H. WILLIAMSON
 
   
Keith H. Williamson
 
   
Senior Vice President, Corporate Secretary and General Counsel
 


 
 

 
EXHIBIT INDEX 
     
Exhibit
   
Number
 
Description
 
99.1
 
 
Press release of Centene Corporation issued December 31, 2008.




EX-99.1 2 exhibit991.htm PRESS RELEASE DATED DECEMBER 31, 2008 exhibit991.htm
Exhibit 99.1
 
 
N E W S  R E L E A S E
 
 
 Contact:  
Investor Relations Inquiries:
Edmund E. Kroll, Jr.
Senior Vice President, Finance & Investor Relations
(212) 759-0382
   
 
Media Relations Inquiries:
Cary D. Hobbs
Senior Vice President, Business Management & Integration
(314) 725-4477
 
 
FOR IMMEDIATE RELEASE


CENTENE CORPORATION RECEIVES TERMINATION NOTICE
RELATING TO NEW JERSEY TRANSACTION; NO EFFECT ON
SOUTH CAROLINA TRANSACTION

ST. LOUIS, MISSOURI (December 31, 2008)—Centene Corporation (NYSE: CNC) today announced that it has received a termination notice from AMERIGROUP Corporation relating to the previously disclosed agreement to sell certain assets of University Health Plans, Inc. in the State of New Jersey. Centene does not believe that there is cause to terminate the New Jersey transaction and is prepared to pursue all available means to bring the transaction to closure.

The termination notice for New Jersey does not relate to or reference the previously disclosed agreement by Centene to purchase from AMERIGROUP certain assets in South Carolina.  Centene intends to close the South Carolina transaction as contemplated in the first quarter of 2009.

As discussed in Centene’s earnings guidance release and conference call on December 19, 2008, the operations of University Health Plans, Inc. will be classified as discontinued operations, effective with the fourth quarter of 2008.  As a result there is no impact on Centene’s 2009 earnings guidance.


About Centene Corporation
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including the State Children’s Health Insurance Program (SCHIP), as well as Aged, Blind, or Disabled (ABD), Foster Care, Long-Term Care and Medicare (Special Needs Plans).  The Company operates local health plans and offers a range of healthcare solutions for the rising number of uninsured Americans.  It contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, nurse triage, pharmacy benefits management and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.

###
GRAPHIC 3 graphic.gif GRAPHIC begin 644 graphic.gif M1TE&.#EA]P`]`/<``````(````"``("`````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E# M9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1 MA4%65M MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMGFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6W=[>WMSY^CG[.KL M].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX^/K\_/[^_O_[\)^?GWU]??\```#_ M`/__````__\`_P#______R'Y!```````+`````#W`#T`AP```(````"``("` M````@(``@`"`@+^_P,#RE!;C$T:S$Q=3`Z8C([S(]@"]`;3`_?CD\>SDYA#M%7#E#9S5&=3E#@#I(:SM*@CE*C#M2ACQD-)A$)09D%/=$)1A4%65MC&1JEF)JFV%OH6-VE6%SGV=UHVIG;VMG MFVMK:VILE&IPG6YXJ&R+I7-S7EYJ[-O6 MW=[>WMSY^CG[.KL].KO\^SJ\^[N\._Q]>_W__7R^/?O__CX M^/K\_/[^_O_[\)^?GWU]??\```#_`/__````__\`_P#______PC^`.L)'$BP MH,&#"!,J7,BPH<.'$"-*G$BQHL6"[Z"]HE6K%D>.M6"9>W>QI,F3*%.J7#E1 MW9D)(&*XB+$"!`P7*%:X*`&"TS:$Q%"]4N7*E:JA15D-)T>4 MJ-&EK^8E=.?T5=.K5H]:5:KJ:5E73/EP8<&/$C1,/?.=.,DM4/QY\`.&A!8H/+CJS`.U! MQ`,9B7X6#*.@0H,($Q94>`";`84'#B;8QEW!]@0'$E#0&^?`-6S9M"78<8

#&`7?QU[]O';M6\7W[U=NG$&E]C^+#AN7;=V\]"],W#PHUZ?(4F0&(EO M!`F1(H3:(204)#[]^$$X4X\B0]1'!'WV(7B@?$D<\1\2`0JD3BY[H**&."S5 MH\H#,[`P`PTH],#""B"*2&*(+*!P0@?$%%3'!")^B**,)I8X8@\H=+C"##_0 M8\Z.'MKX(0,M'B3.#"NL@".-0$$I4C2`9-0C@BBCDM. MB8(4]:3Q``HH;-D!FEL^T`Q"5W"X9IHS=/``,_74<2:='7B09IH>U,FFH"A8 M4.>=4\5YQ2%$W/#-2J-$`$()+;!PPDZ57HJ""I;BQ.D)'W0`#$%J>$!IIZ=J M^JFGG6X*P@C^.]"##J:H9@J"$-H868(*()S@F0JT`ILJK:JV^NFOM#IP2AT? MU&KLLZIBVH$2]831[*7#?I8%0F"8BBRE$TBCS0BK;@JMIYANBND$QM23RR9A M9(%'!C808ME%\[CR@`01CA=.U+%$-ZR0=-(U#X#`@DPT M;3W3"EN3V"%--"!)TP2.)%9'R%US#3;98XN]0M:8_?;^UUN#@`(N M!OVXX]Q[M\VW3%6&73;AB]/]]02N[%%"X6^+K;C>'L[D@1/UE#&YUVV?:$$X M!H7!=N$33$.-!Z&7?3GAF1L>PP3'U+/'-V0@40(G]81BM4EL:":P9]<2SUFE MH/G*@@DXB<#"`J8(-(<&Q%M*O`N^?H8]\CA5:H(*-]!S3F>?65^^KQW(\+M` MY+0``O,H.#\PSM5GGSSW*'C?O,X?8+G'!L73GO+NM[S]S8]S90"@^0CX`0\< MHG0X!#$79!C18X81`]H\@U5K`E$-F` M2BBP@04"Q:8=24E)4JH9AN8P@1?*R`;^7NK`"28P`0_LBXA&]``1.<`"']GP MASEQH<#2L+XCK2"&4L(B%$\$Q!/IR()K'&CJ`C7D08@$) M,PD]",$`=`UK!#D8A3G$P8HCK!%EZ&*`*^I1JF&E"@A_P$,=_J"'5.*!E7^H M`Q[@@`A9$>N6NV)!!J)!$''L:B>6[)<$>E.!W[BF`KUB5;%&,!L)Z&8V"O`$ M(5Z&K4SMY`>O;"4>LED'6:8R#;P+`S5O:2X4>(`&ZR!(MTI@R:5=PQH9L*:Y M-.5,!C3SF0_^J&=OBC2/4*#"%)GH1@HG,@\+`(UD`KL5-PBB#EIX0`5(VLJ" MK[K5=2/@G4`$UZ&NUI6%>CW(&CR`UK_2H`.62,@6/E?8'DQ@$A!9[%W[:KD> M>(`(ZAA(&";GUZ^FSAH32%QA8W"#]66U(:Z8WP(]D(:!JJ%9\)/^WTYZ\0CJ MG8]X'K##1LD7P,W8#WL4J`7[W#[N]T6QO`F#0;`1O2T$+8I"!H6D!5D_[$%IH,44O7,$$*)$0;2AQ MC?M2H@H8P(E)]!"0\?5`'C::(QC&=X\K>.$)G)#9<"#IO3%\`"$2(@<_=?&% M0'Q`)1*RA@UP,2>#]$!@&Z(&MB)XD!?&8@ER5:W_=@B-?O23#2^<1].R5R&S M<,%-U+7C'CP*(>:00A:RX(4M>"$,6^B"%7)A"`_ M`Y730`8\,*<>'&4GE%V0(AUK+64QD,#^+<#LJAT#"P85R.Y!X#!>3J5L4QZ( M*T+$.>8RE^`'5L9R&K0L:"WCP6I>&.>3[VQG3TV`BCYS,KIN,H%W9H#,C$Y1 M3*+QC4Y[^M.=SNR-99%>I5F@!P-MR,(PUC`0/*`"%I#`!1Y`@5C/6E*BYBBK M+\J_%5Q#'2@M-6GBG)`TU-F##9PP0K(@5*-]P`(.F'6M'W!K"Q2-'0()JD>= MRFT&6*,>2"4?R9;:U(C-[W@H1;<'0,"`7MRX'K2@;%WKBH(?V/@A:_OKO,_* M@K-6]HI"$/5<.]MOK_:[K_V>P![4(4A]BZ@#>A8L80]NV`X\$"&2W3?"_%T_&]J-4W8&=>L!"'8$@J[N:`*^>+=#.ZBI M#P#AW@Z9'L^M2W2=N4\&N>;M`JN;P=&`(`WNBVVGD*MG%;=:T*Y/S&[HTO?,U)!*`W M9`X/T#L6$SQX#._=A[D>_-Z3Q*&<&#[!'-K[BVT@X6);.(R!U#"'/;SXQQL> MBT#,R0W$K@;.%WY3C@]D#/^,X+U+(,:IC^_G9Y^3%'G@[NR=!0MN0A,=XT0( M?F>(RQ;M^S+#`&QH!AOO/7"#7!<_93L6@BK\FOPRTV0%O-<)##S^(&>#T)EO MR<]S0O@,?4R#GV_9W\D.Q$[^YX,@%#_P&_IQHOVO^;[2UAB!^;M6_?2G/P/N M-FK(EEX6X`.IQA`+(QH#\S"O9FL3`&NR-@$1L`+.IX#=`P(RT#04P#_(-H`> M@%W%QG;(Y@'*=A#,9G0(-+(PU,930I MD(+7LX+MIG,T,&]6@B,W8`X),0_B(`[FT(1.:`[AX`YK180BT@,T<"M/X`57 M$`5AX`17L(5A$`57$`8"]R15B`(W$`_=4'LQ,H1M2(1#V`'=5Q"+](8Q8G&* MA0(W$B16PDJ:5,CC:'!$$.FS%W/24*CR""V:,"N;51]K-`.I!9 MA!`!W55-SG)<'(,0RZ4\PH)UT740T\4KK8@]'W`%'`$+'I&,'4$+&Q$/`C&, MY@,L&3`,]6`,%C`"UI0MY5)!U(!!P%*,E*(*S.@1(=&,KS!2-T8,'B!X+Z0" M(+#\60F.:.*/!Z M?P0R[ZB0-G#^@.\V$/-@$_;W9#,@?@:!#3NA?%\S-Q,0"I(@:;%#9B.P!QM5 M?#/P-2$B:K_P`(VYS?^\T`F#CE7%I5J(VDPKQ#C7H7:+!/`P0"?0P$.P0#"KP`>5S M@RD0#(7@`:(!&LZE`7J0E(MY@4@G$.\`!80Y09@9&B`(D2+(6R28$">(BB[P M`)$`5+!E0!5PE@+1#4-0`1[(/9U!;K)5F)5R#G:Y$/3085%B(CAR`FMP"S`'.9@A@7^1@-UZ0MG M8HE-$B55"9&/R(=W>'$'<8A[:(G-29W2Z0[N.9W1>9WUD`6(V(99J9H"40L/ M4"5MB")0LE21EXA5TB'!=YOU8`V34B[E(@$6<`(5\#&XE"D>``CUL':>PG3` M@@(Y<`,VH`,ST*$?2@,=&J)((#[%TG.S2).9X)JX^**CN8L'44HC0RM9)UT; M<"SJHCP?&J(>J@,D>@,S`*0ML"W26(P9H`P$,0^3$$'"([;HRZ44@LK MY0LV-556%0R]L%[L108-8#2-%C0JE,V91F5 M6(D"1>(RC,!^LE>M<``)E5` M\>.#Y!4!0`"-]9"`^#.;\E,_U3-1MA29^8.!=;E7Q&6#/[B9!V%L'>29)5@Z MI]FNJJ5TO]49'<`$-\.N\I.:!V$%YY5>>IF#\#2;F+E`PI9>3#.3H[`G8$)( M,+0D7_(`/R#^CWGB)R<;LR62LD'4!!;S)5,R2-QI$*Z0G(`DGJ0X$&GPB"F; M(PX$FB>0LRFBLB%"LU#2`9P3!DF+0R^6K0:!#DU@8@#Z)0(JLTW+)4_"M>UB MEZH@!*;"H)/R+;92`GCP8])S;*HR*>V4BR`P!"@JBN:4IP61!A-@2M;TIY9W M*K_X7(F@=93*:,$RH707J8@:+1E0)`;!"A)P+BNI.N"8ME2ZC?+4C:EJE^5@ M!1T@*063,4HE`3:@"Z73&K111"*C-)S!4^!3IRWP,5EYIWI+$/3(:C(#N!!I M42P`,G":45]F$&7P`/`H;J3K,*_+:A^`0,:;ET+\`G(TZ("O9:%`=T+\3$`/R.Q`O,L#_&\`E\)#(2E=E MI01?8`6?\`F\4`X&X04/T`'_N[_N*\$E+,`F_`!W@+H(2A#H@`W+``4,@@3T,0QW]!#; M<`W:@`U43,56K`W7@`U:K,5[+*!RG8@ M4`5W4`5,``5?H`F:P,&6T0UD7,99C,7^5[S&:SQ2?$S&7:S&PWL0X3#&:RR= M@'S(@=S%UZ`&66`#]!$%0C`,SQ`+L>"E1UP/CA'*?_G),\FW,"D&:-`$:#(! M9%`-GX#'!T#*[^8.R:`)W.`8]2`,BZ`)B^#!LOS+I!R1)9`#D$`%&"!F'*`( M]9`,B[`(]P#,IU4.S;Q0`Z'+>=S`T)S-6;4P,[`(59`S67<`@<`+,JG-%%$- MBX`/_PH.^/`)X&#.\'Q:>C(&?M`!^R9?/\4-O!#/*N$.^.#,_!S0[Q8&/H`) M--!;GWD0^GP/#-W!2WH/O,#0X/`,#)T,RQS1PC`/!Q#1O/`,*00.$=W0OES- M%3T/%'T/&5W^#R;-T"Q]#XF<#*^\P;S0R`!8S0D(.7T`3A#KSP"CP M#&0MU18M(<+`UJ]_=7#BP[_'`L#H0ZXW=G)@%7H8-K$ M70_O70^6_=5U"0YX'-CU4`XQ3)/-^+H.#U M8-R:D-("P0U0_/-_H_=#IG!CE@,?4S%`+C@[JH-K#/1`GGN-&#M4*?MN+P.($ M$0MYO%X'D-L%\>$A#LS/<-D-4"&[W,"PO0B=/1`R[L&U;,L& MP/F6B'67$W5*OW4@>#H MO)`->>WD]0`.4%T-!?'6Y*S2>;W7!L$-N^S+68X/EN'JV[WHLIS6(S-\/YN MT:[<,AGQ]X+^#AJO[=AN$.CLS@5Q`*\5>WQXF!U1C_Y'$N$%D>Z).^R^#NZY]0E^KMZ"UOUE[*[DOJ]-W.RX*^WN6\ M]"SA[DU>#NOL]NAPV5^F#EF^"!Y]]>DLOZ)NZ_C=]9H`ZRV.]J*F#EQ^#XEA MW`8OYJ.NTB.^P>JP7BY.XH7.'%L?G?40^O>P7J+>Y-6Y`=0#V3']#+]O^^]>ZLT<"[G?U3#^WO0.SE!O M_?\`P_WO4^+!N)+IA!< MH$6QYBFL=P#?(H<5P1T(I"D0OG+UY@GC*/#316X4'-5I+H M5&[9<")TE_5B3ZQ1ZZES:E8AU*=KP94]6X^NUI[@^&),RVWK4L*%#1]&G#CI MST^#%3^&'%GR9,J5*?,*:EGS9LZ=/7\:QHB9)VC2I4V?/LWMDR9>J%V_AAU; ']NS'`0$`.S\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----